Prostate cancer is common in Australia, with one in six men diagnosed by age 85. Stereotactic radiation therapy is a precise and effective treatment for both early and advanced prostate cancer, delivering high doses of radiation to target and kill cancer cells with minimal risk to healthy tissues. Recent studies show that this therapy is as effective, less invasive, and has fewer side effects compared to surgery and standard radiation therapy. It is available in many Australian hospitals with no out-of-pocket costs for patients. The therapy is cost-effective and has the potential to become a standard treatment for prostate cancer.
Source link